WallStreetZenWallStreetZen

NASDAQ: SNDX
Syndax Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for SNDX

Based on 6 analysts offering 12 month price targets for Syndax Pharmaceuticals Inc.
Min Forecast
$23.00+19.36%
Avg Forecast
$35.50+84.22%
Max Forecast
$45.00+133.52%

Should I buy or sell SNDX stock?

Based on 6 analysts offering ratings for Syndax Pharmaceuticals Inc.
Strong Buy
Strong Buy
4 analysts 66.67%
Buy
1 analysts 16.67%
Hold
1 analysts 16.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SNDX stock forecasts and price targets.

SNDX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-21
lockedlocked$00.00+00.00%2024-05-09
lockedlocked$00.00+00.00%2024-05-09
lockedlocked$00.00+00.00%2024-05-09
lockedlocked$00.00+00.00%2024-01-31
Mizuho
Bottom 18%
18
Strong BuyInitiates Coverage On$45.00+133.52%2023-12-22

1 of 1

Forecast return on equity

Is SNDX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
27.86%

Forecast return on assets

Is SNDX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

SNDX revenue forecast

What is SNDX's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$27.1M
Avg 2 year Forecast
$85.1M
Avg 3 year Forecast
$192.3M

SNDX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SNDX$19.27$35.50+84.22%Strong Buy
PTGX$28.15$40.00+42.10%Strong Buy
SANA$7.50$13.50+80.00%Buy
HRMY$29.40$39.80+35.37%Hold
ARDX$6.86$14.60+112.83%Strong Buy
View Top Biotech Stocks

Syndax Pharmaceuticals Stock Forecast FAQ

Is Syndax Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: SNDX) stock is to Strong Buy SNDX stock.

Out of 6 analysts, 4 (66.67%) are recommending SNDX as a Strong Buy, 1 (16.67%) are recommending SNDX as a Buy, 1 (16.67%) are recommending SNDX as a Hold, 0 (0%) are recommending SNDX as a Sell, and 0 (0%) are recommending SNDX as a Strong Sell.

If you're new to stock investing, here's how to buy Syndax Pharmaceuticals stock.

What is SNDX's revenue growth forecast for 2024-2026?

(NASDAQ: SNDX) Syndax Pharmaceuticals's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.39%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.64%.

Syndax Pharmaceuticals's revenue in 2024 is $0.On average, 4 Wall Street analysts forecast SNDX's revenue for 2024 to be $2,299,324,908, with the lowest SNDX revenue forecast at $560,064,725, and the highest SNDX revenue forecast at $7,053,925,980. On average, 4 Wall Street analysts forecast SNDX's revenue for 2025 to be $7,230,274,130, with the lowest SNDX revenue forecast at $6,280,543,734, and the highest SNDX revenue forecast at $8,498,706,000.

In 2026, SNDX is forecast to generate $16,345,646,237 in revenue, with the lowest revenue forecast at $15,495,180,727 and the highest revenue forecast at $18,187,230,840.

What is SNDX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: SNDX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is SNDX's Price Target?

According to 6 Wall Street analysts that have issued a 1 year SNDX price target, the average SNDX price target is $35.50, with the highest SNDX stock price forecast at $45.00 and the lowest SNDX stock price forecast at $23.00.

On average, Wall Street analysts predict that Syndax Pharmaceuticals's share price could reach $35.50 by May 21, 2025. The average Syndax Pharmaceuticals stock price prediction forecasts a potential upside of 84.22% from the current SNDX share price of $19.27.

What is SNDX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: SNDX) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.